The Nebraska Biocontainment Unit, a specialized facility for treating highly infectious diseases, is available to assist with a potential Ebola response following the conclusion of a patient's stay for hantavirus, according to health officials. The unit, located at the Nebraska Medical Center in Omaha, has a history of treating patients with Ebola and other dangerous pathogens.
The recent hantavirus patient was discharged after successful treatment, freeing up the unit's resources. As of May 23, 2026, there are no active Ebola cases in the United States, but the unit remains on standby as part of national preparedness efforts. The Nebraska Biocontainment Unit is one of a few such facilities in the country, designed to isolate and treat patients with highly contagious diseases.
Health experts emphasize that the unit's availability does not indicate an immediate threat, but rather a proactive measure. The unit has previously treated patients during the 2014-2016 West Africa Ebola outbreak and the 2022 Marburg virus case. Officials continue to monitor global health situations and maintain readiness.
